COVID-19 Disruption of Trials is in Decline


Applied Clinical Trials

Most disruptions to clinical trials over the past three months were caused by the suspension of enrollment, followed by slow enrollment, and delayed initiation, says GlobalData, a data and analytics company. The number of disrupted trials began to fall between June and July. 

For more information, click here.

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.